Alvotech (ALVOW) — 6-K Filings

6-K Filings (50)

• 6-K Filing — Dec 23, 2025
• 6-K Filing — Dec 19, 2025
• Alvotech Reaffirms 2025 Outlook, Issues 2026 Guidance — Dec 17, 2025 Risk: low
  On December 16, 2025, Alvotech provided a business update, reaffirming its full-year 2025 revenue outlook previously updated on November 2, 2025. The company al
• Alvotech Files November 2025 6-K Report — Nov 24, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on November 24, 2025. This report is for the month of November 2025 and indicates that Alvotech files it
• Alvotech Files November 2025 6-K Report — Nov 20, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on November 20, 2025. This report is for the month of November 2025 and indicates that Alvotech files it
• Alvotech Files Routine 6-K Report — Nov 17, 2025 Risk: low
  Alvotech filed a Form 6-K on November 17, 2025, reporting for the month of November 2025. The company, headquartered in Luxembourg, is a foreign private issuer
• Alvotech Files Routine 6-K for November 2025 — Nov 12, 2025 Risk: low
  Alvotech filed a Form 6-K on November 12, 2025, reporting for the month of November 2025. The company, incorporated in Luxembourg, operates in the biological pr
• 6-K Filing — Nov 6, 2025
• 6-K Filing — Nov 3, 2025
• Alvotech Files October 2025 6-K Report — Oct 22, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on October 22, 2025, to report its activities for the month of October 2025. The filing indicates that A
• Alvotech Files 6-K Report — Oct 6, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on October 6, 2025. This filing is a report of a foreign private issuer and indicates that Alvotech file
• Alvotech Files September 2025 6-K Report — Sep 22, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on September 22, 2025, reporting for the month of September 2025. The company, incorporated in Luxembour
• Alvotech Files 6-K Report, Incorporates Exhibits — Aug 13, 2025 Risk: low
  Alvotech filed a Form 6-K on August 13, 2025, for the period ending June 30, 2025. The filing is a report of a foreign private issuer and incorporates by refere
• Alvotech Files 6-K, Incorporates Information into SEC Filings — Jul 28, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on July 28, 2025. This report incorporates by reference information into its existing registration state
• Alvotech Files Form 6-K Report — Jul 10, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on July 10, 2025. This filing is a report of a foreign private issuer and indicates that Alvotech files
• Alvotech Files Form 6-K with SEC — Jul 9, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on July 9, 2025. The filing is a report of a foreign private issuer and indicates that Alvotech files an
• Alvotech Files July 2025 Report on Form 6-K — Jul 1, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on July 1, 2025, to report its activities for the month of July 2025. The company is incorporated in Lux
• Alvotech Files June 2025 6-K Report — Jun 25, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on June 25, 2025. This report is for the month of June 2025 and indicates that Alvotech files its annual
• Alvotech Files June 2025 Report (6-K) — Jun 23, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on June 23, 2025, to report its activities for the month of June 2025. The company is incorporated in Lu
• Alvotech Files 6-K Report — Jun 12, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on June 12, 2025, to report information for the month of June 2025. The company is incorporated in Luxem
• Alvotech Files June 2025 Form 6-K — Jun 11, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on June 11, 2025, for the month of June 2025. The company is incorporated in Luxembourg and its principa
• Alvotech Files 6-K Report — Jun 5, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on June 5, 2025. The filing is a report of a foreign private issuer and indicates that Alvotech files an
• Alvotech Files Form 6-K with SEC — May 28, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on May 28, 2025. The filing is a report of a foreign private issuer and indicates that Alvotech files it
• Alvotech Files May 2025 6-K Report — May 27, 2025 Risk: low
  Alvotech filed a Form 6-K on May 27, 2025, for the month of May 2025. The filing includes several exhibits, such as press releases and financial statements, whi
• Alvotech Files 6-K, Incorporates into Registration Statements — May 9, 2025 Risk: low
  Alvotech filed a Form 6-K on May 9, 2025, to report its activities for the month of May 2025. This report is incorporated by reference into several of Alvotech'
• Alvotech Files May 2025 6-K Report — May 8, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on May 8, 2025. This report is for the month of May 2025 and indicates that Alvotech files its annual re
• Alvotech Files 6-K Report, Confirms 20-F Filing — May 7, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on May 7, 2025. This filing is a report of a foreign private issuer and indicates that Alvotech files it
• Alvotech Files Routine 6-K Report — May 5, 2025 Risk: low
  Alvotech filed a Form 6-K on May 5, 2025, reporting its status as a foreign private issuer. The company, incorporated in Luxembourg, is involved in the biologic
• Alvotech Files March 2025 6-K Report — Mar 27, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on March 27, 2025, reporting for the month of March 2025. The company, incorporated in Luxembourg, is pr
• Alvotech Files March 2025 6-K Report — Mar 26, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on March 26, 2025. This report is for the month of March 2025 and indicates that Alvotech files its annu
• Alvotech Files Routine 6-K Report — Mar 20, 2025 Risk: low
  Alvotech filed a Form 6-K on March 20, 2025, reporting its activities for the month of March 2025. The company, incorporated in Luxembourg, operates in the biol
• Alvotech Files 6-K Report — Mar 18, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on March 18, 2025. This filing is a report of a foreign private issuer and indicates that Alvotech files
• Alvotech Files Form 6-K for February 2025 — Feb 24, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on February 24, 2025, for the month of February 2025. The company is incorporated in Luxembourg and its
• Alvotech Files February 2025 6-K Report — Feb 18, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on February 18, 2025. This report is for the month of February 2025 and indicates that Alvotech files it
• Alvotech Files January 2025 Report on Form 6-K — Jan 27, 2025 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on January 27, 2025, reporting its activities for the month of January 2025. The filing indicates that A
• Alvotech Files December 2024 6-K Report — Dec 23, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on December 23, 2024. This report is for the month of December 2024 and indicates that Alvotech files it
• Alvotech Files 6-K Report — Nov 13, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on November 13, 2024. The filing is a report of a foreign private issuer and indicates that Alvotech fil
• Alvotech Files November 2024 Report (6-K) — Nov 4, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on November 4, 2024, to report information for the month of November 2024. The filing indicates that Alv
• Alvotech Files October 2024 Report on Form 6-K — Oct 22, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on October 22, 2024, to report its activities for the month of October 2024. The filing indicates that A
• Alvotech Files 6-K Report — Oct 10, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on October 10, 2024. The filing is a report of a foreign private issuer and indicates that Alvotech file
• Alvotech Files 6-K, Confirms 20-F Filing — Aug 15, 2024 Risk: low
  Alvotech filed a Form 6-K on August 15, 2024, reporting its status as a foreign private issuer. The filing confirms Alvotech's intention to file annual reports
• Alvotech Files 6-K for June 30, 2024 Period — Aug 15, 2024 Risk: low
  Alvotech filed a Form 6-K on August 15, 2024, for the period ending June 30, 2024. The report is a filing by a foreign private issuer and includes information i
• Alvotech Files Routine 6-K with SEC — Jul 22, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on July 22, 2024, indicating it will file its annual reports under Form 20-F. The filing does not contai
• Alvotech Files Form 6-K with SEC — Jul 11, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on July 11, 2024. The filing is a report of a foreign private issuer and indicates that Alvotech files a
• Alvotech Files Form 6-K for July 2024 — Jul 3, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on July 3, 2024, reporting for the month of July 2024. The filing indicates that Alvotech is a foreign p
• Alvotech Files Routine 6-K Report — Jul 2, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on July 2, 2024, reporting for the month of July 2024. The company, incorporated in Luxembourg, is prima
• Alvotech Files Form 6-K with SEC — Jul 1, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on July 1, 2024, to report information as a foreign private issuer. The filing confirms Alvotech's princ
• Alvotech Files Form 6-K, Confirms 20-F Reporting — Jun 26, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on June 26, 2024. The filing indicates that the company is a foreign private issuer and will file its an
• Alvotech Files Form 6-K with SEC — Jun 18, 2024 Risk: low
  Alvotech, a biopharmaceutical company, filed a Form 6-K on June 18, 2024. This filing is a report of a foreign private issuer and indicates that Alvotech files
• Alvotech Files for $200M At-the-Market Offering — Jun 14, 2024 Risk: medium
  On June 14, 2024, Alvotech entered into an Open Market Sale Agreement with an unspecified sales agent. This agreement allows Alvotech to issue and sell up to $2

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX